kneat.com (KSI) Stock Price, News & Analysis

Company Overview

kneat.com Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance. In addition, it provides software-related services including training, installation, upgrades, consulting and maintenance.

Key Stats

• Today's Range: C$6.54 to C$6.87
• 50-Day Range: C$5.72 to C$6.75
• 52-Week Range: C$3.98 to C$7.25
• Volume: 37,503 shs
• Average Volume: 69,622 shs
• Market Capitalization: C$631.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: C$6.00
• Consensus Rating: Strong Buy

kneat.com Stock Analysis - MarketRank™

kneat.com scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.8 / 5
• Analyst Rating: Strong Buy

Consensus Rating

kneat.com has received a consensus rating of Strong Buy. The company's average rating score is 3.67, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

kneat.com has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of kneat.com is -72.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of kneat.com is -72.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

kneat.com has a PEG Ratio of 597.67. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

kneat.com has a P/B Ratio of 18.77. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for KSI.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

kneat.com does not currently pay a dividend.

Dividend Growth

kneat.com does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for KSI.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

News Sentiment

kneat.com has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, kneat.com insiders have not sold or bought any company stock.

Percentage Held by Insiders

25.96% of the stock of kneat.com is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 13.03% of the stock of kneat.com is held by institutions.

KSI Stock Analysis - Frequently Asked Questions

How have KSI shares performed this year?

kneat.com's stock was trading at C$5.86 at the beginning of the year. Since then, KSI stock has increased by 15.2% and is now trading at C$6.75.
View the best growth stocks for 2025 here.

How were kneat.com's earnings last quarter?

kneat.com, inc. (TSE:KSI) announced its quarterly earnings data on Wednesday, November, 6th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.05) by $0.06. kneat.com had a negative net margin of 17.59% and a negative trailing twelve-month return on equity of 29.61%.
Read the conference call transcript.

How do I buy shares of kneat.com?

Shares of KSI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of kneat.com own?

Based on aggregate information from My MarketBeat watchlists, some other companies that kneat.com investors own include Arista Networks (ANET), PayPal (PYPL), NVIDIA (NVDA), MercadoLibre (MELI), Enterprise Products Partners (EPD), Nextera Energy Partners (NEP) and Enbridge (ENB).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 5/16/2025

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: TSE:KSI
• CIK: N/A
• Web: www.kneat.com
• Phone: 353 6 120 3826
• Fax: N/A
• Employees: 293
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$6.00
• High Stock Price Target: C$6.00
• Low Stock Price Target: C$6.00
• Potential Upside/Downside: -11.5%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C($0.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 597.67
• Net Income: C$-8,617,763.37
• Net Margins: -17.59%
• Pretax Margin: N/A
• Return on Equity: -29.61%
• Return on Assets: -9.84%

Debt

• Debt-to-Equity Ratio: 85.50
• Current Ratio: 1.43
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: C$48.99 million
• Price / Sales: 12.94
• Cash Flow: C$0.51 per share
• Price / Cash Flow: 13.18
• Book Value: C$0.36 per share
• Price / Book: 18.86

Miscellaneous

• Outstanding Shares: 93,501,552
• Free Float: N/A
• Market Cap: C$633.94 million
• Optionable: Not Optionable
• Beta: 1.08